Bioequivalence
171
2
2
139
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Published Results
11 trials with published results (6%)
Research Maturity
139 completed trials (81% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 171 trials
100.0%
+13.4% vs benchmark
2%
3 trials in Phase 3/4
8%
11 of 139 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 139 completed trials
Clinical Trials (171)
A Bioequivalence Study of Advil Tablet (Mini) (Ibuprofen 200 mg) Versus Advil Tablet (Ibuprofen 200 mg) in Healthy Adult Subjects Under Fasted Conditions and Bioavailability Assessment of Advil Tablet (Mini) Under Fed Conditions
A Randomized, Double-Blind, Positive-Controlled, Parallel Pharmacokinetic Phase I Clinical Study of Cetuximab Injection Versus Erbitux in Healthy Male Subjects
Bioequivalence and Adhesion of a Rotigotine Patch in Healthy Subjects
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 50 mg/1000 mg in Healthy Subjects, Fed Study.
Clinical Study to Determine Bioequivalence of Oral Tamsulosin Products as 0.4 mg Prolonged-release Tablets in Male Subjects Under Fed Conditions
Study on Sapropterin Dihydrochloride Oral Suspension in Healthy Subjects Under Fed Conditions
Bioequivalence Study of Levetiracetam 1500 mg Coated Granules in Healthy, Male Subjects
Bioavailability of KBP-5074 Tablet vs Capsule Formulations
Bioequivalence Study of Paclitaxel Protein-bound Particles for Injectable Suspension (Albumin-bound) in Breast Cancer Patients
A Study to Learn if There is a Difference in the Blood Levels of Acetylsalicylic Acid When Taken as Different Chewable Tablets on an Empty Stomach by Healthy Participants
Bioequivalence Study of Fluvastatin Sodium Extended Release Tablets in Healthy Participants
Study in Healthy Male Subjects to Demonstrate Bioequivalence of 1600 μg Selexipag Administered as Eight Tablets of 200 μg or as Single Tablet of 1600 μg
Bioequivalence Clinical Trial of Recombinant Human Follicle-stimulating Hormone JZB30
Coffee Bioequivalence Trial
Bioequivalence Study of Test and Reference 120 mg Etoricoxib Film-coated Tablets in Healthy Volunteers
A Study of TEPEZZA Subcutaneous Administration in Healthy Adults
Bioequivalence Study of Palbociclib 125 mg Capsules of Iclos vs. Ibrance (Palbociclib) Capsules 125 mg
Bioequivalence Study of GP30101 800 mg (GEROPHARM) Versus PREZISTA® 800 mg ("Jonson&Jonson", Russia)
Open Randomized Study of Comparative Pharmacokinetics and Biosimilarity of GP40221 (GEROPHARM LLC, Russia) and Ozempic®.
Rivastigmine Bioequivalence Trial With Multiple Applications of Transdermal Patches (9.5 mg/24 h)